Blogs The Fibroblast Growth Factor Receptor 4 (FGFR4)

The Fibroblast Growth Factor Receptor 4 (FGFR4)

What is the Fibroblast Growth Factor Receptor 4 (FGFR4)?

Fibroblast Growth Factor 4 (FGF4) is an essential growth factor involved in various cellular processes, including cell proliferation, differentiation, and embryonic development.1 FGF4 belongs to the fibroblast growth factor family and is known for its role in signaling pathways that drive cell growth and morphogenesis. Its activity is primarily mediated by specific fibroblast growth factor receptors (FGFRs), which vary in tissue distribution and have distinct roles in developmental and physiological functions.

FGFR4 Blog

What is FGFR4's Role in Human Physiology?

FGFR4 plays essential roles in development and homeostasis by mediating various physiological processes. Different fibroblast growth factors (FGFs) activate FGFR4, influencing specific tissues and driving distinct biological effects:

  • Muscle Development: FGFR4 is highly expressed in skeletal muscle progenitor cells, where it promotes both cell proliferation and differentiation, crucial for limb and trunk muscle formation during embryogenesis.2 This receptor facilitates the transition of muscle stem cells to differentiated muscle fibers, a critical step in musculoskeletal development​
  • Stem Cell Regulation: In stem cell biology, FGFR4 activation by FGF4 triggers MAPK and PI3K-Akt signaling pathways, which are essential for stem cell proliferation and early differentiation​.1 This pathway allows FGFR4 to maintain a balance between growth and specialization, critical for early developmental stages.
  • Tumor Growth: FGFR4 is increasingly studied in cancer research due to its role in tumor progression. In certain cancers, elevated FGFR4 expression contributes to uncontrolled cell proliferation and survival, making it a target of interest in developing FGFR inhibitors​.3

FGFR4 activation by its ligands triggers a variety of signaling cascades, leading to physiological responses essential for cell growth, tissue development, and potentially oncogenic progression, highlighting its importance in both normal physiology and disease states.

What is FGFR4’s Role in Disease and Drug Discovery?

Dysregulation of FGFR4 signaling is associated with several diseases and disorders, making it an important target for therapeutic intervention:

  • Cancer: Overexpression or mutations in FGFR4 have been linked to the progression of several cancers, including liver and breast cancer. FGFR4 activation promotes cell proliferation, migration, and survival, facilitating tumor growth and metastasis. Inhibiting FGFR4 signaling is under investigation as a potential treatment for these cancers, with FGFR4 inhibitors showing promise in reducing tumor progression​.3,1
  • Muscle Development Disorders: FGFR4’s role in muscle progenitor cell proliferation and differentiation makes it critical in muscle formation. Dysregulation of FGFR4 during development can lead to congenital muscle defects and impaired skeletal muscle growth​.2
  • Fibrosis and Liver Disease: FGFR4 is also implicated in liver health, where abnormal FGFR4 signaling can contribute to fibrosis and hepatocellular carcinoma. The receptor’s regulation of bile acid metabolism and cellular repair processes in liver tissues makes it a key focus in research on liver diseases and fibrosis-related interventions​.3

Given the diverse roles of FGFR4 in health and disease, significant interest exists in developing FGFR4-targeted therapies. FGFR4 inhibitors are being evaluated for their potential to control cancer progression, while FGFR4 modulation could address muscle repair in degenerative diseases.

INDIGO's FGFR4 Reporter Assays

Designed to facilitate research into Fibroblast Growth Factor Receptor 4 (FGFR4) receptor signaling and drug discovery, INDIGO Biosciences’ FGFR4, FGFR4/b-Klotho, and FGFR4/a-Klotho assays offer a comprehensive platform for evaluating FGFR4 activity and screening potential therapeutic compounds. Our assays provide researchers with an all-inclusive luciferase reporter system that includes—in addition to engineered, pre-transfected reporter cells—optimized media for use during cell culture and in diluting the user’s test samples, a reference agonist, luciferase detection reagent, and a cell culture-ready assay plate. INDIGO Biosciences can also perform the FGFR4 assay in our lab as a service for researchers.

INDIGO’s cell-based reporter assays allow scientists to accelerate the drug discovery process and enable the development of novel therapies for FGFR4-related diseases. They provide an efficient way to examine a compound for its ability to regulate receptor activity in agonist, inverse-agonist, or antagonist mode using luciferase reporter gene technology. Since the receptor binding controls the expression of the luciferase reporter gene, luciferase activity in the cells can be correlated directly with the activity of the receptor.

INDIGO Biosciences provides comprehensive technical support and expertise to assist researchers in interpreting FGFR4 reporter assay results. Contact us today to learn more about INDIGO's FGFR4 reporter assay kits and our screening capabilities!

 

Works Cited

  1. Kook SH, Jeon YM, Lim SS, Jang MJ, Cho ES, et al. (2013) Fibroblast Growth Factor-4 Enhances Proliferation of Mouse Embryonic Stem Cells via Activation of c-Jun Signaling. PLOS ONE 8(8): e71641. https://doi.org/10.1371/journal.pone.0071641
  2. Irène Marics, Françoise Padilla, Jean-François Guillemot, Martin Scaal, Christophe Marcelle; FGFR4 signaling is a necessary step in limb muscle differentiation. Development1 October 2002; 129 (19): 4559–4569. doi: https://doi.org/10.1242/dev.129.19.4559
  3. Yanan Liu, Meng Cao, Yuepiao Cai, Xiaokun Li, Chengguang Zhao, Ri Cui; Dissecting the Role of the FGF19-FGFR4 Signaling Pathway in Cancer Development and Progression. Frontiers in Cell and Development Biology 19 February 2020; doi:  https://doi.org/10.3389/fcell.2020.00095